世界のリポソーム開発サービス市場予測2023-2029:リポソーム、脂質ナノ粒子

【英語タイトル】Liposome Development Service Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料(MMG23FB2193)・商品コード:MMG23FB2193
・発行会社(調査会社):Market Monitor Global
・発行日:2023年2月
・ページ数:100
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のリポソーム開発サービス市場規模と予測を収録しています。・世界のリポソーム開発サービス市場:売上、2018年-2023年、2024年-2029年
・世界のリポソーム開発サービス市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のリポソーム開発サービス市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「リポソーム」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

リポソーム開発サービスのグローバル主要企業は、Precision NanoSystems、Evonik、Merck KGaA、Genevant Sciences、Exelead、Avanti Polar Lipids、Nippon Fine Chemical、Lipoid、Polymun Scientific、Corden Pharma、Acuitas Therapeutics、Creative Biolabs、Creative Biostructure、T&T Scientific、FormuMax Scientific、PlantaCorp、CD Bioparticlesなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、リポソーム開発サービスのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のリポソーム開発サービス市場:タイプ別、2018年-2023年、2024年-2029年
世界のリポソーム開発サービス市場:タイプ別市場シェア、2022年
・リポソーム、脂質ナノ粒子

世界のリポソーム開発サービス市場:用途別、2018年-2023年、2024年-2029年
世界のリポソーム開発サービス市場:用途別市場シェア、2022年
・前臨床、臨床、商用

世界のリポソーム開発サービス市場:地域・国別、2018年-2023年、2024年-2029年
世界のリポソーム開発サービス市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるリポソーム開発サービスのグローバル売上、2018年-2023年
・主要企業におけるリポソーム開発サービスのグローバル売上シェア、2022年
・主要企業におけるリポソーム開発サービスのグローバル販売量、2018年-2023年
・主要企業におけるリポソーム開発サービスのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Precision NanoSystems、Evonik、Merck KGaA、Genevant Sciences、Exelead、Avanti Polar Lipids、Nippon Fine Chemical、Lipoid、Polymun Scientific、Corden Pharma、Acuitas Therapeutics、Creative Biolabs、Creative Biostructure、T&T Scientific、FormuMax Scientific、PlantaCorp、CD Bioparticles

*************************************************************

・調査・分析レポートの概要
リポソーム開発サービス市場の定義
市場セグメント
世界のリポソーム開発サービス市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のリポソーム開発サービス市場規模
世界のリポソーム開発サービス市場規模:2022年 VS 2029年
世界のリポソーム開発サービス市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのリポソーム開発サービスの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のリポソーム開発サービス製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:リポソーム、脂質ナノ粒子
リポソーム開発サービスのタイプ別グローバル売上・予測

・用途別市場分析
用途区分:前臨床、臨床、商用
リポソーム開発サービスの用途別グローバル売上・予測

・地域別市場分析
地域別リポソーム開発サービス市場規模 2022年と2029年
地域別リポソーム開発サービス売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Precision NanoSystems、Evonik、Merck KGaA、Genevant Sciences、Exelead、Avanti Polar Lipids、Nippon Fine Chemical、Lipoid、Polymun Scientific、Corden Pharma、Acuitas Therapeutics、Creative Biolabs、Creative Biostructure、T&T Scientific、FormuMax Scientific、PlantaCorp、CD Bioparticles

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Liposome Development Service Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Liposome Development Service Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Liposome Development Service Overall Market Size
2.1 Global Liposome Development Service Market Size: 2022 VS 2029
2.2 Global Liposome Development Service Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Liposome Development Service Players in Global Market
3.2 Top Global Liposome Development Service Companies Ranked by Revenue
3.3 Global Liposome Development Service Revenue by Companies
3.4 Top 3 and Top 5 Liposome Development Service Companies in Global Market, by Revenue in 2022
3.5 Global Companies Liposome Development Service Product Type
3.6 Tier 1, Tier 2 and Tier 3 Liposome Development Service Players in Global Market
3.6.1 List of Global Tier 1 Liposome Development Service Companies
3.6.2 List of Global Tier 2 and Tier 3 Liposome Development Service Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Liposome Development Service Market Size Markets, 2022 & 2029
4.1.2 Liposomes
4.1.3 Lipid Nanoparticles
4.2 By Type – Global Liposome Development Service Revenue & Forecasts
4.2.1 By Type – Global Liposome Development Service Revenue, 2018-2023
4.2.2 By Type – Global Liposome Development Service Revenue, 2024-2029
4.2.3 By Type – Global Liposome Development Service Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Liposome Development Service Market Size, 2022 & 2029
5.1.2 Preclinical
5.1.3 Clinical
5.1.4 Commercial
5.2 By Application – Global Liposome Development Service Revenue & Forecasts
5.2.1 By Application – Global Liposome Development Service Revenue, 2018-2023
5.2.2 By Application – Global Liposome Development Service Revenue, 2024-2029
5.2.3 By Application – Global Liposome Development Service Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Liposome Development Service Market Size, 2022 & 2029
6.2 By Region – Global Liposome Development Service Revenue & Forecasts
6.2.1 By Region – Global Liposome Development Service Revenue, 2018-2023
6.2.2 By Region – Global Liposome Development Service Revenue, 2024-2029
6.2.3 By Region – Global Liposome Development Service Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Liposome Development Service Revenue, 2018-2029
6.3.2 US Liposome Development Service Market Size, 2018-2029
6.3.3 Canada Liposome Development Service Market Size, 2018-2029
6.3.4 Mexico Liposome Development Service Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Liposome Development Service Revenue, 2018-2029
6.4.2 Germany Liposome Development Service Market Size, 2018-2029
6.4.3 France Liposome Development Service Market Size, 2018-2029
6.4.4 U.K. Liposome Development Service Market Size, 2018-2029
6.4.5 Italy Liposome Development Service Market Size, 2018-2029
6.4.6 Russia Liposome Development Service Market Size, 2018-2029
6.4.7 Nordic Countries Liposome Development Service Market Size, 2018-2029
6.4.8 Benelux Liposome Development Service Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Liposome Development Service Revenue, 2018-2029
6.5.2 China Liposome Development Service Market Size, 2018-2029
6.5.3 Japan Liposome Development Service Market Size, 2018-2029
6.5.4 South Korea Liposome Development Service Market Size, 2018-2029
6.5.5 Southeast Asia Liposome Development Service Market Size, 2018-2029
6.5.6 India Liposome Development Service Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Liposome Development Service Revenue, 2018-2029
6.6.2 Brazil Liposome Development Service Market Size, 2018-2029
6.6.3 Argentina Liposome Development Service Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Liposome Development Service Revenue, 2018-2029
6.7.2 Turkey Liposome Development Service Market Size, 2018-2029
6.7.3 Israel Liposome Development Service Market Size, 2018-2029
6.7.4 Saudi Arabia Liposome Development Service Market Size, 2018-2029
6.7.5 UAE Liposome Development Service Market Size, 2018-2029
7 Liposome Development Service Companies Profiles
7.1 Precision NanoSystems
7.1.1 Precision NanoSystems Company Summary
7.1.2 Precision NanoSystems Business Overview
7.1.3 Precision NanoSystems Liposome Development Service Major Product Offerings
7.1.4 Precision NanoSystems Liposome Development Service Revenue in Global Market (2018-2023)
7.1.5 Precision NanoSystems Key News & Latest Developments
7.2 Evonik
7.2.1 Evonik Company Summary
7.2.2 Evonik Business Overview
7.2.3 Evonik Liposome Development Service Major Product Offerings
7.2.4 Evonik Liposome Development Service Revenue in Global Market (2018-2023)
7.2.5 Evonik Key News & Latest Developments
7.3 Merck KGaA
7.3.1 Merck KGaA Company Summary
7.3.2 Merck KGaA Business Overview
7.3.3 Merck KGaA Liposome Development Service Major Product Offerings
7.3.4 Merck KGaA Liposome Development Service Revenue in Global Market (2018-2023)
7.3.5 Merck KGaA Key News & Latest Developments
7.4 Genevant Sciences
7.4.1 Genevant Sciences Company Summary
7.4.2 Genevant Sciences Business Overview
7.4.3 Genevant Sciences Liposome Development Service Major Product Offerings
7.4.4 Genevant Sciences Liposome Development Service Revenue in Global Market (2018-2023)
7.4.5 Genevant Sciences Key News & Latest Developments
7.5 Exelead
7.5.1 Exelead Company Summary
7.5.2 Exelead Business Overview
7.5.3 Exelead Liposome Development Service Major Product Offerings
7.5.4 Exelead Liposome Development Service Revenue in Global Market (2018-2023)
7.5.5 Exelead Key News & Latest Developments
7.6 Avanti Polar Lipids
7.6.1 Avanti Polar Lipids Company Summary
7.6.2 Avanti Polar Lipids Business Overview
7.6.3 Avanti Polar Lipids Liposome Development Service Major Product Offerings
7.6.4 Avanti Polar Lipids Liposome Development Service Revenue in Global Market (2018-2023)
7.6.5 Avanti Polar Lipids Key News & Latest Developments
7.7 Nippon Fine Chemical
7.7.1 Nippon Fine Chemical Company Summary
7.7.2 Nippon Fine Chemical Business Overview
7.7.3 Nippon Fine Chemical Liposome Development Service Major Product Offerings
7.7.4 Nippon Fine Chemical Liposome Development Service Revenue in Global Market (2018-2023)
7.7.5 Nippon Fine Chemical Key News & Latest Developments
7.8 Lipoid
7.8.1 Lipoid Company Summary
7.8.2 Lipoid Business Overview
7.8.3 Lipoid Liposome Development Service Major Product Offerings
7.8.4 Lipoid Liposome Development Service Revenue in Global Market (2018-2023)
7.8.5 Lipoid Key News & Latest Developments
7.9 Polymun Scientific
7.9.1 Polymun Scientific Company Summary
7.9.2 Polymun Scientific Business Overview
7.9.3 Polymun Scientific Liposome Development Service Major Product Offerings
7.9.4 Polymun Scientific Liposome Development Service Revenue in Global Market (2018-2023)
7.9.5 Polymun Scientific Key News & Latest Developments
7.10 Corden Pharma
7.10.1 Corden Pharma Company Summary
7.10.2 Corden Pharma Business Overview
7.10.3 Corden Pharma Liposome Development Service Major Product Offerings
7.10.4 Corden Pharma Liposome Development Service Revenue in Global Market (2018-2023)
7.10.5 Corden Pharma Key News & Latest Developments
7.11 Acuitas Therapeutics
7.11.1 Acuitas Therapeutics Company Summary
7.11.2 Acuitas Therapeutics Business Overview
7.11.3 Acuitas Therapeutics Liposome Development Service Major Product Offerings
7.11.4 Acuitas Therapeutics Liposome Development Service Revenue in Global Market (2018-2023)
7.11.5 Acuitas Therapeutics Key News & Latest Developments
7.12 Creative Biolabs
7.12.1 Creative Biolabs Company Summary
7.12.2 Creative Biolabs Business Overview
7.12.3 Creative Biolabs Liposome Development Service Major Product Offerings
7.12.4 Creative Biolabs Liposome Development Service Revenue in Global Market (2018-2023)
7.12.5 Creative Biolabs Key News & Latest Developments
7.13 Creative Biostructure
7.13.1 Creative Biostructure Company Summary
7.13.2 Creative Biostructure Business Overview
7.13.3 Creative Biostructure Liposome Development Service Major Product Offerings
7.13.4 Creative Biostructure Liposome Development Service Revenue in Global Market (2018-2023)
7.13.5 Creative Biostructure Key News & Latest Developments
7.14 T&T Scientific
7.14.1 T&T Scientific Company Summary
7.14.2 T&T Scientific Business Overview
7.14.3 T&T Scientific Liposome Development Service Major Product Offerings
7.14.4 T&T Scientific Liposome Development Service Revenue in Global Market (2018-2023)
7.14.5 T&T Scientific Key News & Latest Developments
7.15 FormuMax Scientific
7.15.1 FormuMax Scientific Company Summary
7.15.2 FormuMax Scientific Business Overview
7.15.3 FormuMax Scientific Liposome Development Service Major Product Offerings
7.15.4 FormuMax Scientific Liposome Development Service Revenue in Global Market (2018-2023)
7.15.5 FormuMax Scientific Key News & Latest Developments
7.16 PlantaCorp
7.16.1 PlantaCorp Company Summary
7.16.2 PlantaCorp Business Overview
7.16.3 PlantaCorp Liposome Development Service Major Product Offerings
7.16.4 PlantaCorp Liposome Development Service Revenue in Global Market (2018-2023)
7.16.5 PlantaCorp Key News & Latest Developments
7.17 CD Bioparticles
7.17.1 CD Bioparticles Company Summary
7.17.2 CD Bioparticles Business Overview
7.17.3 CD Bioparticles Liposome Development Service Major Product Offerings
7.17.4 CD Bioparticles Liposome Development Service Revenue in Global Market (2018-2023)
7.17.5 CD Bioparticles Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Liposome Development Service Market Opportunities & Trends in Global Market
Table 2. Liposome Development Service Market Drivers in Global Market
Table 3. Liposome Development Service Market Restraints in Global Market
Table 4. Key Players of Liposome Development Service in Global Market
Table 5. Top Liposome Development Service Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Liposome Development Service Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Liposome Development Service Revenue Share by Companies, 2018-2023
Table 8. Global Companies Liposome Development Service Product Type
Table 9. List of Global Tier 1 Liposome Development Service Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Liposome Development Service Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Liposome Development Service Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Liposome Development Service Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Liposome Development Service Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Liposome Development Service Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Liposome Development Service Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Liposome Development Service Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Liposome Development Service Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Liposome Development Service Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Liposome Development Service Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Liposome Development Service Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Liposome Development Service Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Liposome Development Service Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Liposome Development Service Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Liposome Development Service Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Liposome Development Service Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Liposome Development Service Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Liposome Development Service Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Liposome Development Service Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Liposome Development Service Revenue, (US$, Mn), 2024-2029
Table 30. Precision NanoSystems Company Summary
Table 31. Precision NanoSystems Liposome Development Service Product Offerings
Table 32. Precision NanoSystems Liposome Development Service Revenue (US$, Mn) & (2018-2023)
Table 33. Precision NanoSystems Key News & Latest Developments
Table 34. Evonik Company Summary
Table 35. Evonik Liposome Development Service Product Offerings
Table 36. Evonik Liposome Development Service Revenue (US$, Mn) & (2018-2023)
Table 37. Evonik Key News & Latest Developments
Table 38. Merck KGaA Company Summary
Table 39. Merck KGaA Liposome Development Service Product Offerings
Table 40. Merck KGaA Liposome Development Service Revenue (US$, Mn) & (2018-2023)
Table 41. Merck KGaA Key News & Latest Developments
Table 42. Genevant Sciences Company Summary
Table 43. Genevant Sciences Liposome Development Service Product Offerings
Table 44. Genevant Sciences Liposome Development Service Revenue (US$, Mn) & (2018-2023)
Table 45. Genevant Sciences Key News & Latest Developments
Table 46. Exelead Company Summary
Table 47. Exelead Liposome Development Service Product Offerings
Table 48. Exelead Liposome Development Service Revenue (US$, Mn) & (2018-2023)
Table 49. Exelead Key News & Latest Developments
Table 50. Avanti Polar Lipids Company Summary
Table 51. Avanti Polar Lipids Liposome Development Service Product Offerings
Table 52. Avanti Polar Lipids Liposome Development Service Revenue (US$, Mn) & (2018-2023)
Table 53. Avanti Polar Lipids Key News & Latest Developments
Table 54. Nippon Fine Chemical Company Summary
Table 55. Nippon Fine Chemical Liposome Development Service Product Offerings
Table 56. Nippon Fine Chemical Liposome Development Service Revenue (US$, Mn) & (2018-2023)
Table 57. Nippon Fine Chemical Key News & Latest Developments
Table 58. Lipoid Company Summary
Table 59. Lipoid Liposome Development Service Product Offerings
Table 60. Lipoid Liposome Development Service Revenue (US$, Mn) & (2018-2023)
Table 61. Lipoid Key News & Latest Developments
Table 62. Polymun Scientific Company Summary
Table 63. Polymun Scientific Liposome Development Service Product Offerings
Table 64. Polymun Scientific Liposome Development Service Revenue (US$, Mn) & (2018-2023)
Table 65. Polymun Scientific Key News & Latest Developments
Table 66. Corden Pharma Company Summary
Table 67. Corden Pharma Liposome Development Service Product Offerings
Table 68. Corden Pharma Liposome Development Service Revenue (US$, Mn) & (2018-2023)
Table 69. Corden Pharma Key News & Latest Developments
Table 70. Acuitas Therapeutics Company Summary
Table 71. Acuitas Therapeutics Liposome Development Service Product Offerings
Table 72. Acuitas Therapeutics Liposome Development Service Revenue (US$, Mn) & (2018-2023)
Table 73. Acuitas Therapeutics Key News & Latest Developments
Table 74. Creative Biolabs Company Summary
Table 75. Creative Biolabs Liposome Development Service Product Offerings
Table 76. Creative Biolabs Liposome Development Service Revenue (US$, Mn) & (2018-2023)
Table 77. Creative Biolabs Key News & Latest Developments
Table 78. Creative Biostructure Company Summary
Table 79. Creative Biostructure Liposome Development Service Product Offerings
Table 80. Creative Biostructure Liposome Development Service Revenue (US$, Mn) & (2018-2023)
Table 81. Creative Biostructure Key News & Latest Developments
Table 82. T&T Scientific Company Summary
Table 83. T&T Scientific Liposome Development Service Product Offerings
Table 84. T&T Scientific Liposome Development Service Revenue (US$, Mn) & (2018-2023)
Table 85. T&T Scientific Key News & Latest Developments
Table 86. FormuMax Scientific Company Summary
Table 87. FormuMax Scientific Liposome Development Service Product Offerings
Table 88. FormuMax Scientific Liposome Development Service Revenue (US$, Mn) & (2018-2023)
Table 89. FormuMax Scientific Key News & Latest Developments
Table 90. PlantaCorp Company Summary
Table 91. PlantaCorp Liposome Development Service Product Offerings
Table 92. PlantaCorp Liposome Development Service Revenue (US$, Mn) & (2018-2023)
Table 93. PlantaCorp Key News & Latest Developments
Table 94. CD Bioparticles Company Summary
Table 95. CD Bioparticles Liposome Development Service Product Offerings
Table 96. CD Bioparticles Liposome Development Service Revenue (US$, Mn) & (2018-2023)
Table 97. CD Bioparticles Key News & Latest Developments
List of Figures
Figure 1. Liposome Development Service Segment by Type in 2022
Figure 2. Liposome Development Service Segment by Application in 2022
Figure 3. Global Liposome Development Service Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Liposome Development Service Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Liposome Development Service Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Liposome Development Service Revenue in 2022
Figure 8. By Type - Global Liposome Development Service Revenue Market Share, 2018-2029
Figure 9. By Application - Global Liposome Development Service Revenue Market Share, 2018-2029
Figure 10. By Type - Global Liposome Development Service Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Liposome Development Service Revenue Market Share, 2018-2029
Figure 12. By Application - Global Liposome Development Service Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Liposome Development Service Revenue Market Share, 2018-2029
Figure 14. By Region - Global Liposome Development Service Revenue Market Share, 2018-2029
Figure 15. By Country - North America Liposome Development Service Revenue Market Share, 2018-2029
Figure 16. US Liposome Development Service Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Liposome Development Service Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Liposome Development Service Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Liposome Development Service Revenue Market Share, 2018-2029
Figure 20. Germany Liposome Development Service Revenue, (US$, Mn), 2018-2029
Figure 21. France Liposome Development Service Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Liposome Development Service Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Liposome Development Service Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Liposome Development Service Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Liposome Development Service Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Liposome Development Service Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Liposome Development Service Revenue Market Share, 2018-2029
Figure 28. China Liposome Development Service Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Liposome Development Service Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Liposome Development Service Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Liposome Development Service Revenue, (US$, Mn), 2018-2029
Figure 32. India Liposome Development Service Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Liposome Development Service Revenue Market Share, 2018-2029
Figure 34. Brazil Liposome Development Service Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Liposome Development Service Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Liposome Development Service Revenue Market Share, 2018-2029
Figure 37. Turkey Liposome Development Service Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Liposome Development Service Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Liposome Development Service Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Liposome Development Service Revenue, (US$, Mn), 2018-2029
Figure 41. Precision NanoSystems Liposome Development Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Evonik Liposome Development Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Merck KGaA Liposome Development Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Genevant Sciences Liposome Development Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Exelead Liposome Development Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Avanti Polar Lipids Liposome Development Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Nippon Fine Chemical Liposome Development Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Lipoid Liposome Development Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Polymun Scientific Liposome Development Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Corden Pharma Liposome Development Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Acuitas Therapeutics Liposome Development Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Creative Biolabs Liposome Development Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Creative Biostructure Liposome Development Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. T&T Scientific Liposome Development Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. FormuMax Scientific Liposome Development Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. PlantaCorp Liposome Development Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. CD Bioparticles Liposome Development Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



★調査レポート[世界のリポソーム開発サービス市場予測2023-2029:リポソーム、脂質ナノ粒子] (コード:MMG23FB2193)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のリポソーム開発サービス市場予測2023-2029:リポソーム、脂質ナノ粒子]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆